Pyramax (pyronaridine-artesunate) Treatment of Acute Uncomplicated Malaria in Adults and children

Save 13%

Title: Adult
₦3,500 ₦4,000


Pyramax is used to treat uncomplicated malaria, caused by two types of malaria parasites, Plasmodium falciparum and Plasmodium vivax. 'Uncomplicated' means the disease does not involve severe, life-threatening symptoms
Pyramax, a fixed-dose combination of pyronaridine and artesunate co-developed by MMV and Shin Poong Pharmaceutical Co. Ltd., South Korea, is the newest ACT combination to be approved by a Stringent Regulatory Authority. 

Mode of administration The dose should be taken orally once a day for three days with or without food. Dosage in adults and children Pyramax tablets should be taken orally as a single daily dose for three consecutive days. A granule formulation is available for children weighing between 5 kg to under 20 kg

Payment & Security

AirtelTigo Money American Express Mastercard MTN Mobile Money Ozow Visa

Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

Estimate shipping

You may also like

Recently viewed